Doseology Sciences Inc.
DOSEF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$801.16K
Close$
$0.08
12.6% downside
Current Fair Value
12.6% downsideOvervalued by 12.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $801,162.00 |
|---|---|
| Enterprise Value | $433,795.00 |
| Earnings per Share | $-0.07 |
| Beta | 2.24 |
| Outstanding Shares | 12,185,318 |
Return
| Return on Equity | -106.23% |
|---|---|
| Return on Assets | -98.95% |
| Return on Invested Capital | -107.98% |
Valuation & Multiples
| P/E Ratio | -0.67 |
|---|---|
| PEG | -0.15 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 5.34 |
| Enterprise Value to EBIT | -0.37 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Doseology Sciences Inc.
3 employees
CEO: Christopher Jackson
Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications. The company's primary focus lies in the research, development, and commercializ...